3.565 USD
-0.02 (-0.7%)
We assign a fundamental rating of 3 out of 10 to QIPT. QIPT was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of QIPT have multiple concerns. While showing a medium growth rate, QIPT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- QIPT had negative earnings in the past year.
- In the past year QIPT had a positive cash flow from operations.
- QIPT had negative earnings in 4 of the past 5 years.
- In the past 5 years QIPT always reported a positive cash flow from operatings.
1.2 Ratios
- With a Return On Assets value of -3.78%, QIPT is not doing good in the industry: 62.75% of the companies in the same industry are doing better.
- QIPT has a Return On Equity (-10.66%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.78% | ||
| ROE | -10.66% | ||
| ROIC | N/A |
ROA(3y)-2.55%
ROA(5y)-1.94%
ROE(3y)-6.5%
ROE(5y)-4.81%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 72.21%, QIPT belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
- QIPT's Gross Margin has been stable in the last couple of years.
- QIPT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 72.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5Y-0.1%
2. Health
2.1 Basic Checks
- QIPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for QIPT has been increased compared to 1 year ago.
- The number of shares outstanding for QIPT has been increased compared to 5 years ago.
- Compared to 1 year ago, QIPT has a worse debt to assets ratio.
2.2 Solvency
- QIPT has an Altman-Z score of 0.45. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
- With a Altman-Z score value of 0.45, QIPT is not doing good in the industry: 75.49% of the companies in the same industry are doing better.
- QIPT has a debt to FCF ratio of 4.69. This is a neutral value as QIPT would need 4.69 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 4.69, QIPT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
- A Debt/Equity ratio of 0.95 indicates that QIPT is somewhat dependend on debt financing.
- The Debt to Equity ratio of QIPT (0.95) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | 4.69 | ||
| Altman-Z | 0.45 |
ROIC/WACCN/A
WACC8.54%
2.3 Liquidity
- QIPT has a Current Ratio of 1.05. This is a normal value and indicates that QIPT is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.05, QIPT is not doing good in the industry: 67.65% of the companies in the same industry are doing better.
- A Quick Ratio of 0.71 indicates that QIPT may have some problems paying its short term obligations.
- QIPT has a worse Quick ratio (0.71) than 79.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
- The earnings per share for QIPT have decreased strongly by -108.33% in the last year.
- QIPT shows a decrease in Revenue. In the last year, the revenue decreased by -0.23%.
- The Revenue has been growing by 27.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-108.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-0.23%
Revenue growth 3Y20.59%
Revenue growth 5Y27.58%
Sales Q2Q%29.8%
3.2 Future
- Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 103.14% on average per year.
- QIPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.15% yearly.
EPS Next Y28.6%
EPS Next 2Y-6.88%
EPS Next 3Y103.14%
EPS Next 5YN/A
Revenue Next Year27.89%
Revenue Next 2Y14.09%
Revenue Next 3Y33.15%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
- Also next year QIPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- 88.24% of the companies in the same industry are more expensive than QIPT, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, QIPT is valued cheaper than 94.12% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.11 | ||
| EV/EBITDA | 6.35 |
4.3 Compensation for Growth
- QIPT's earnings are expected to grow with 103.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.88%
EPS Next 3Y103.14%
5. Dividend
5.1 Amount
- No dividends for QIPT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:QIPT (1/21/2026, 3:58:00 PM)
3.565
-0.02 (-0.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-15 2025-12-15/bmo
Earnings (Next)02-09 2026-02-09
Inst Owners49.34%
Inst Owner Change0.29%
Ins Owners16.51%
Ins Owner Change0%
Market Cap154.86M
Revenue(TTM)245.36M
Net Income(TTM)-10.70M
Analysts76.36
Price Target3.93 (10.24%)
Short Float %1.93%
Short Ratio0.95
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.5%
Min EPS beat(2)-6.96%
Max EPS beat(2)1.96%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.78%
Min Revenue beat(2)-0.65%
Max Revenue beat(2)2.22%
Revenue beat(4)1
Avg Revenue beat(4)-2.56%
Min Revenue beat(4)-9.06%
Max Revenue beat(4)2.22%
Revenue beat(8)1
Avg Revenue beat(8)-5.12%
Revenue beat(12)2
Avg Revenue beat(12)-4.55%
Revenue beat(16)2
Avg Revenue beat(16)-4.15%
PT rev (1m)5.21%
PT rev (3m)4.84%
EPS NQ rev (1m)-233.33%
EPS NQ rev (3m)-233.33%
EPS NY rev (1m)-218.18%
EPS NY rev (3m)-218.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.63 | ||
| P/FCF | 6.11 | ||
| P/OCF | 4.11 | ||
| P/B | 1.54 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.35 |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)0.58
FCFY16.36%
OCF(TTM)0.87
OCFY24.34%
SpS5.65
BVpS2.31
TBVpS-0.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.78% | ||
| ROE | -10.66% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 72.21% | ||
| FCFM | 10.33% |
ROA(3y)-2.55%
ROA(5y)-1.94%
ROE(3y)-6.5%
ROE(5y)-4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5Y-0.1%
F-Score4
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.95 | ||
| Debt/FCF | 4.69 | ||
| Debt/EBITDA | 2.32 | ||
| Cap/Depr | 27.16% | ||
| Cap/Sales | 5.04% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 91.37% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.45 |
F-Score4
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)22.45%
Cap/Depr(5y)27.1%
Cap/Sales(3y)4.11%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y28.6%
EPS Next 2Y-6.88%
EPS Next 3Y103.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.23%
Revenue growth 3Y20.59%
Revenue growth 5Y27.58%
Sales Q2Q%29.8%
Revenue Next Year27.89%
Revenue Next 2Y14.09%
Revenue Next 3Y33.15%
Revenue Next 5YN/A
EBIT growth 1Y-400.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1993.49%
EBIT Next 3Y243.93%
EBIT Next 5YN/A
FCF growth 1Y1.08%
FCF growth 3Y13.83%
FCF growth 5Y12.69%
OCF growth 1Y6.53%
OCF growth 3Y12.69%
OCF growth 5Y21.85%
QUIPT HOME MEDICAL CORP / QIPT FAQ
Can you provide the ChartMill fundamental rating for QUIPT HOME MEDICAL CORP?
ChartMill assigns a fundamental rating of 3 / 10 to QIPT.
Can you provide the valuation status for QUIPT HOME MEDICAL CORP?
ChartMill assigns a valuation rating of 3 / 10 to QUIPT HOME MEDICAL CORP (QIPT). This can be considered as Overvalued.
Can you provide the profitability details for QUIPT HOME MEDICAL CORP?
QUIPT HOME MEDICAL CORP (QIPT) has a profitability rating of 2 / 10.
What is the financial health of QUIPT HOME MEDICAL CORP (QIPT) stock?
The financial health rating of QUIPT HOME MEDICAL CORP (QIPT) is 2 / 10.
What is the earnings growth outlook for QUIPT HOME MEDICAL CORP?
The Earnings per Share (EPS) of QUIPT HOME MEDICAL CORP (QIPT) is expected to grow by 28.6% in the next year.